Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Pediatr Hematol Oncol. 2022 Mar 9;39(7):650–657. doi: 10.1080/08880018.2022.2047850

TABLE 2.

Regression analysis of Latinx enclave index scores and MRD positivity.

Crude OR (95% CI) Adjusted OR (95% CI)b
Latinx Quartile p=0.03a p=0.01a
 LEI-1 (Lowest) 1.00 (Ref) 1.00 (Ref)
 LEI-2 1.00 (0.23–4.62) 0.69 (0.14–3.54)
 LEI-3 1.67 (0.48–6.79) 1.55 (0.41–6.68)
 LEI-4 (Highest) 2.62 (0.81–10.24) 2.91 (0.85–11.96)
Male (vs Female) 1.66 (0.83–3.41) 1.61 (0.75–3.54)
High NCI Risk (vs Standard) 2.51 (1.26–5.09) 3.09 (0.98–9.79)
Unfavorable Cytogenetics (vs favorable or neutral) 1.45 (0.55–3.77) 1.13 (0.37–3.27)
a

p-for-trend.

b

Adjusted for sex (male, female), overweight/obesity (not shown), age at diagnosis (not shown), unfavorable cytogenetics (defined as BCR-ABL1 fusion, KMT2A rearrangement, hypodiploidy, or iAMP21 at diagnosis), and NCI risk group (standard, high).